GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (GREY:PMKIF) » Definitions » Change In Receivables

PT Merck Tbk (PT Merck Tbk) Change In Receivables : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is PT Merck Tbk Change In Receivables?

PT Merck Tbk's change in receivables for the quarter that ended in Mar. 2024 was $0.00 Mil. It means PT Merck Tbk's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

PT Merck Tbk's change in receivables for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means PT Merck Tbk's Accounts Receivable stayed the same from Dec. 2022 to Dec. 2023 .

PT Merck Tbk's Accounts Receivable for the quarter that ended in Mar. 2024 was $10.71 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. PT Merck Tbk's Days Sales Outstanding for the three months ended in Mar. 2024 was 60.36.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. PT Merck Tbk's liquidation value for the three months ended in Mar. 2024 was $17.91 Mil.


PT Merck Tbk Change In Receivables Historical Data

The historical data trend for PT Merck Tbk's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk Change In Receivables Chart

PT Merck Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Merck Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PT Merck Tbk Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Merck Tbk  (GREY:PMKIF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

PT Merck Tbk's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=10.706/16.184*91
=60.36

2. In Ben Graham's calculation of liquidation value, PT Merck Tbk's accounts receivable are only considered to be worth 75% of book value:

PT Merck Tbk's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=13.012-16.074+0.75 * 10.706+0.5 * 25.885
=17.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Merck Tbk Change In Receivables Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Merck Tbk (PT Merck Tbk) Business Description

Traded in Other Exchanges
Address
Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines to treat cancer, multiple sclerosis, infertility, growth disorders, and cardiovascular and metabolic diseases, as well as chronic diseases.

PT Merck Tbk (PT Merck Tbk) Headlines

No Headlines